EGFR and diabetic kidney disease: We provide the first evidence for YY1 regulate EGFR persistent activation, transformation between PKM2 dimer and tetramer, HIF-1α accumulation and aberrant glycolysis and fibrosis in DKD through the ARAP1-AS2/ARAP1 axis.